141 related articles for article (PubMed ID: 9831134)
1. Binding specificity of a class II-restricted hepatitis B epitope by DR molecules from responder and nonresponder vaccine recipients.
Schuenke KW; Cook RG; Rich RR
Hum Immunol; 1998 Dec; 59(12):783-93. PubMed ID: 9831134
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
Rosloniec EF; Whittington KB; Zaller DM; Kang AH
J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
[TBL] [Abstract][Full Text] [Related]
3. Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response after immunisation with hepatitis B surface antigen.
Langö-Warensjö A; Cardell K; Lindblom B
Tissue Antigens; 1998 Oct; 52(4):374-80. PubMed ID: 9820601
[TBL] [Abstract][Full Text] [Related]
4. Minimal association of alleles of human leukocyte antigen class II gene and long-term antibody response to hepatitis B vaccine vaccinated during infancy.
Xu B; Zhu D; Bi Y; Wang Y; Hu Y; Zhou YH
Vaccine; 2017 Apr; 35(18):2457-2462. PubMed ID: 28320591
[TBL] [Abstract][Full Text] [Related]
5. The immune response to hepatitis B vaccine in humans: inheritance patterns in families.
Kruskall MS; Alper CA; Awdeh Z; Yunis EJ; Marcus-Bagley D
J Exp Med; 1992 Feb; 175(2):495-502. PubMed ID: 1531063
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B surface antigen presentation and HLA-DRB1*- lessons from twins and peptide binding studies.
Kruger A; Adams P; Hammer J; Böcher WO; Schneider PM; Rittner C; Hoehler T
Clin Exp Immunol; 2005 May; 140(2):325-32. PubMed ID: 15807858
[TBL] [Abstract][Full Text] [Related]
7. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen.
Caillat-Zucman S; Gimenez JJ; Wambergue F; Albouze G; Lebkiri B; Naret C; Moynot A; Jungers P; Bach JF
Kidney Int; 1998 Jun; 53(6):1626-30. PubMed ID: 9607193
[TBL] [Abstract][Full Text] [Related]
8. Cellular recognition and HLA restriction of a midsequence HBsAg peptide in hepatitis B vaccinated individuals.
Deulofeut H; Iglesias A; Mikael N; Bing DH; Awdeh Z; Yunis J; Marcus-Bagley D; Kruskall MS; Alper CA; Yunis EJ
Mol Immunol; 1993 Jul; 30(10):941-8. PubMed ID: 8341285
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.
Desombere I; Gijbels Y; Verwulgen A; Leroux-Roels G
Clin Exp Immunol; 2000 Dec; 122(3):390-9. PubMed ID: 11122245
[TBL] [Abstract][Full Text] [Related]
10. Anti-HBV neonatal immunization with recombinant vaccine. Part II. Molecular basis of the impaired alloreactivity.
Martinetti M; Cuccia M; Daielli C; Ambroselli F; Gatti C; Pizzochero C; Belloni C; Orsolini P; Salvaneschi L
Vaccine; 1995 Apr; 13(6):555-60. PubMed ID: 7483776
[TBL] [Abstract][Full Text] [Related]
11. [Association of humans leucocitary antigens with humoral nonresponsive to hepatitis B vaccine in chronic hemodialysis patients].
de Sousa Júnior JX; de Monte Neto JT; de Castro JA; de Andrade HM; do Monte SJ
Rev Soc Bras Med Trop; 2004; 37(1):15-7. PubMed ID: 15042175
[TBL] [Abstract][Full Text] [Related]
12. Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response.
Sakai A; Noguchi E; Fukushima T; Tagawa M; Iwabuchi A; Kita M; Kakisaka K; Miyasaka A; Takikawa Y; Sumazaki R
Vaccine; 2017 Jan; 35(4):703-710. PubMed ID: 28043736
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles.
Patil NS; Pashine A; Belmares MP; Liu W; Kaneshiro B; Rabinowitz J; McConnell H; Mellins ED
J Immunol; 2001 Dec; 167(12):7157-68. PubMed ID: 11739539
[TBL] [Abstract][Full Text] [Related]
14. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination.
McDermott AB; Zuckerman JN; Sabin CA; Marsh SG; Madrigal JA
Tissue Antigens; 1997 Jul; 50(1):8-14. PubMed ID: 9243749
[TBL] [Abstract][Full Text] [Related]
15. Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype.
Hatae K; Kimura A; Okubo R; Watanabe H; Erlich HA; Ueda K; Nishimura Y; Sasazuki T
Eur J Immunol; 1992 Jul; 22(7):1899-905. PubMed ID: 1352502
[TBL] [Abstract][Full Text] [Related]
16. Characterization of hepatitis B virus surface antigen-specific CD4+ T cells in hepatitis B vaccine non-responders.
Suzuki T; Yamauchi K; Kuwata T; Hayashi N
J Gastroenterol Hepatol; 2001 Aug; 16(8):898-903. PubMed ID: 11555104
[TBL] [Abstract][Full Text] [Related]
17. The influence of major histocompatibility complex class II genes and T-cell Vbeta repertoire on response to immunization with HBsAg.
Höhler T; Meyer CU; Notghi A; Stradmann-Bellinghausen B; Schneider PM; Starke R; Zepp F; Sänger R; Clemens R; Meyer zum Büschenfelde KH; Rittner C
Hum Immunol; 1998 Apr; 59(4):212-8. PubMed ID: 9568796
[TBL] [Abstract][Full Text] [Related]
18. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B.
Höhler T; Gerken G; Notghi A; Lubjuhn R; Taheri H; Protzer U; Löhr HF; Schneider PM; Meyer zum Büschenfelde KH; Rittner C
J Hepatol; 1997 Mar; 26(3):503-7. PubMed ID: 9075656
[TBL] [Abstract][Full Text] [Related]
19. The relationship between predicted peptide-MHC class II affinity and T-cell activation in a HLA-DRbeta1*0401 transgenic mouse model.
Hill JA; Wang D; Jevnikar AM; Cairns E; Bell DA
Arthritis Res Ther; 2003; 5(1):R40-8. PubMed ID: 12716452
[TBL] [Abstract][Full Text] [Related]
20. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
